The relative timing of exposure to phagocytosable particulates and to osteoclastogenic cytokines is critically important in the determination of myeloid cell fate

Journal of Immunology

Volumn 185, Issue 2, 2010, Pages 1265-1273

  James, Douglas E ^a   Nestor, Bryan J ^a   Sculco, Thomas P ^a   Ivashkiv, Lionel B ^a   Ross, F Patrick ^a   Goldring, Steven R ^a   Purdue, P Edward ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; CATHEPSIN K; COLONY STIMULATING FACTOR RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; POLY(METHYL METHACRYLATE); SILICON DIOXIDE; TITANIUM; TNFRSF11A PROTEIN, MOUSE;

ARTICLE; BONE; BONE MARROW CELL; CELL FATE; DOWN REGULATION; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MONOCYTE; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOBLOTTING; METABOLISM; OSTEOCLAST; PARTICULATE MATTER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

CATHEPSIN K; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; MACROPHAGE COLONY-STIMULATING FACTOR; MONOCYTES; MYELOID CELLS; OSTEOCLASTS; PARTICULATE MATTER; PHAGOCYTOSIS; POLYMETHYL METHACRYLATE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SILICON DIOXIDE; TIME FACTORS; TITANIUM;

EID: 77955491869     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902808     Document Type: Article

References (32)

1. Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
2. Brodbeck, W. G., and J. M. Anderson. 2009. Giant cell formation and function. Curr. Opin. Hematol. 16: 53-57.
3. Ross, F. P. 2006. M-CSF, c-Fms, and signaling in osteoclasts and their precursors. Ann. N. Y. Acad. Sci. 1068: 110-116.
4. Ha, H., J. H. Lee, H. N. Kim, H. B. Kwak, H. M. Kim, S. E. Lee, J. H. Rhee, H. H. Kim, and Z. H. Lee. 2008. Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta. J. Immunol. 180: 1382-1389.
5. Takami, M., N. Kim, J. Rho, and Y. Choi. 2002. Stimulation by toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169: 1516-1523. (Pubitemid 34809198)
6. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFNgamma. Nature 408: 600-605.
7. Zou, W., and Z. Bar-Shavit. 2002. Dual modulation of osteoclast differentiation by lipopolysaccharide. J. Bone Miner. Res. 17: 1211-1218.
8. Ji, J.-D., K.-H. Park-Min, Z. Shen, R. J. Fajardo, S. R. Goldring, K. P. McHugh, and L. B. Ivashkiv. 2009. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J. Immunol. 183: 7223-7233.
9. Aderem, A. 2003. Phagocytosis and the inflammatory response. J. Infect. Dis. 187(Suppl 2): S340-S345.
10. Purdue, P. E., P. Koulouvaris, H. G. Potter, B. J. Nestor, and T. P. Sculco. 2007. The cellular and molecular biology of periprosthetic osteolysis. Clin. Orthop. Relat. Res. 454: 251-261.
11. Rimal, B., A. K. Greenberg, and W. N. Rom. 2005. Basic pathogenetic mechanisms in silicosis: current understanding. Curr. Opin. Pulm. Med. 11: 169-173.
12. Rakshit, D. S., J. T. Lim, K. Ly, L. B. Ivashkiv, B. J. Nestor, T. P. Sculco, and P. E. Purdue. 2006. Involvement of complement receptor 3 (CR3) and scavenger receptor in macrophage responses to wear debris. J. Orthop. Res. 24: 2036-2044.
13. Clohisy, J. C., E. Frazier, T. Hirayama, and Y. Abu-Amer. 2003. RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J. Orthop. Res. 21: 202-212.
14. Yamanaka, Y., W. Abu-Amer, D. Foglia, J. Otero, J. C. Clohisy, and Y. Abu- Amer. 2008. NFAT2 is an essential mediator of orthopedic particle-induced osteoclastogenesis. J. Orthop. Res. 26: 1577-1584.
15. Willert, H. G., H. Bertram, and G. H. Buchhorn. 1990. Osteolysis in alloarthroplasty of the hip. The role of bone cement fragmentation. Clin. Orthop. Relat. Res. (258):108-121.
16. Rakshit, D. S., K. Ly, T. K. Sengupta, B. J. Nestor, T. P. Sculco, L. B. Ivashkiv, and P. E. Purdue. 2006. Wear debris inhibition of anti- osteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis. J. Bone Joint Surg. Am. 88: 788-799.
17. McHugh, K., Z. Shen, R. O'Sullivan, T. Crotti, M. Flannery, and S. Goldrin. 2007. Annexin VIII Is a Critical Bone Matrix-dependent Osteoclast Gene Transcriptionally Regulated by RANKL and NFATc1. J. Bone Miner. Res. 22: S379.
18. Kudo, O., Y. Fujikawa, I. Itonaga, A. Sabokbar, T. Torisu, and N. A. Athanasou. 2002. Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J. Pathol. 198: 220-227.
19. Lam, J., S. Takeshita, J. E. Barker, O. Kanagawa, F. P. Ross, and S. L. Teitelbaum. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106: 1481-1488.
20. Takayanagi, H., S. Kim, K. Matsuo, H. Suzuki, T. Suzuki, K. Sato, T. Yokochi, H. Oda, K. Nakamura, N. Ida, et al. 2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416: 744-749. (Pubitemid 34429151)
21. Mochizuki, A., M. Takami, T. Kawawa, R. Suzumoto, T. Sasaki, A. Shiba, H. Tsukasaki, B. Zhao, R. Yasuhara, T. Suzawa, et al. 2006. Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-kappa B ligand. J. Immunol. 177: 4360-4368. (Pubitemid 44469764)
22. Abu-Amer, Y. 2001. IL-4 abrogates osteoclastogenesis through STAT6- dependent inhibition of NF-kappaB. J. Clin. Invest. 107: 1375-1385.
23. Moreno, J. L., M. Kaczmarek, A. D. Keegan, and M. Tondravi. 2003. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood 102: 1078-1086.
24. Hiasa, M., M. Abe, A. Nakano, A. Oda, H. Amou, S. Kido, K. Takeuchi, K. Kagawa, K. Yata, T. Hashimoto, et al. 2009. GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE). Blood 114: 4517-4526.
25. Blobel, C. P. 2005. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6: 32-43.
26. Lee, S. H., J. Rho, D. Jeong, J. Y. Sul, T. Kim, N. Kim, J. S. Kang, T. Miyamoto, T. Suda, S. K. Lee, et al. 2006. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med. 12: 1403-1409.
27. Yagi, M., T. Miyamoto, Y. Sawatani, K. Iwamoto, N. Hosogane, N. Fujita, K. Morita, K. Ninomiya, T. Suzuki, K. Miyamoto, et al. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202: 345-351.
28. Kim, K., S. H. Lee, J. Ha Kim, Y. Choi, and N. Kim. 2008. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22: 176-185.
29. Shen, Z., T. N. Crotti, K. P. McHugh, K. Matsuzaki, E. M. Gravallese, B. E. Bierbaum, and S. R. Goldring. 2006. The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Arthritis Res. Ther. 8: R70.
30. Goldring, S. R., M. Roelke, and J. Glowacki. 1988. Multinucleated cells elicited in response to implants of devitalized bone particles possess receptors for calcitonin. J. Bone Miner. Res. 3: 117-120.
31. Glowacki, J., M. Jasty, and S. Goldring. 1986. Comparison of multinucleated cells elicited in rats by particulate bone, polyethylene, or polymethylmethacrylate. J. Bone Miner. Res. 1: 327-331.
32. Koulouvaris, P., K. Ly, L. B. Ivashkiv, M. P. Bostrom, B. J. Nestor, T. P. Sculco, and P. E. Purdue. 2008. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis. J. Orthop. Res. 26: 106-116.